LY294002, a synthetic compound designed based on the flavonoid quercetin, functions as a PI3K inhibitor, blocking PI3K/AKT signaling, inhibiting glycolysis, and interfering with ATP production, thereby inducing apoptosis in cancer cells [49]. Here, AKT1 is linked to cancer.